Trials / Completed
CompletedNCT01613404
An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis
A Prospective, Observational, Randomized Comparative Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 248 (actual)
- Sponsor
- Janssen Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the 90 day and 12 month composite end point of death (all-cause mortality) and hospitalization in incident hemodialysis patients randomized to receive support from a dedicated case manager (intervention group) versus those not receiving support from a dedicated case manager (control group).
Detailed description
This is multicenter, prospective, observational, and randomized (the study drug is assigned by chance), 1-year study, in academic and community-based nephrology clinical practices that will examine the impact of a facility nurse case manager. In this study a group of patients guideline- based, algorithm- driven approach to hemodialysis initiation with targets (as per Canadian Society of Nephrology and/or International guidelines) will be used with facility nurse case manager and in control group same approach will be used without facility nurse case manager. Patients will be treated with any approved erythropoiesis stimulating agent for the correction of anemia, according to guidance in the current approved product monographs. All treatments will be prescribed by the physician according to actual clinical practice or standard of care for chronic kidney disease. The entire study duration for each participant will be approximately 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Patients will be treated with approved erythropoiesis stimulating agent (Eprex or Aranesp) will be administered according to actual clinical practice according to guidance in the current approved product monographs. All patients will receive treatments that are prescribed by their physician according to actual clinical practice. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2012-06-07
- Last updated
- 2016-01-21
Locations
14 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01613404. Inclusion in this directory is not an endorsement.